Square zinc Tablet, Dispersible 20 mg Tanzania - English - Tanzania Medicinces & Medical Devices Authority

square zinc tablet, dispersible 20 mg

square pharmaceuticals limited, bangladesh - zinc sulphate monohydrate - tablet, dispersible - 20 mg

Square Zinc 20 Tablet Kenya - English - Pharmacy and Poisons Board

square zinc 20 tablet

square pharmaceuticals ltd. 48 mohakhali c.a. dhaka-1212 bangladesh - zinc sulphate - tablet - 20 mg - mineral supplements: zinc

Appezinc 30 mg Tablet Philippines - English - FDA (Food And Drug Administration)

appezinc 30 mg tablet

square pharma'l inc - zinc gluconate trihydrate (equiv. to 30 mg elemental zinc) - tablet - 30 mg

Square Zinc 10 Tablet Bangladesh - English - DGDA (Directorate General of Drug Administration)

square zinc 10 tablet

square pharmaceuticals plc, gazipur - zinc - tablet - 10 mg

Square Zinc 20 Tablet Bangladesh - English - DGDA (Directorate General of Drug Administration)

square zinc 20 tablet

square pharmaceuticals plc, gazipur - zinc - tablet - 20 mg

Zincmar 27.50 mg/mL (equivalent to 10 mg elemental Zinc) Syrup (Oral Drops) Philippines - English - FDA (Food And Drug Administration)

zincmar 27.50 mg/ml (equivalent to 10 mg elemental zinc) syrup (oral drops)

marzan pharma corporation - zinc sulfate (as monohydrate) - syrup (oral drops) - 27.50 mg/ml (equivalent to 10 mg elemental zinc)

Incivo European Union - English - EMA (European Medicines Agency)

incivo

janssen-cilag international n.v. - telaprevir - hepatitis c, chronic - antivirals for systemic use - incivo, in combination with peginterferon alfa and ribavirin, is indicated for the treatment of genotype-1 chronic hepatitis c in adult patients with compensated liver disease (including cirrhosis):who are treatment naïve;who have previously been treated with interferon alfa (pegylated or non-pegylated) alone or in combination with ribavirin, including relapsers, partial responders and null responders.

LEQVIO SOLUTION Canada - English - Health Canada

leqvio solution

novartis pharmaceuticals canada inc - inclisiran (inclisiran sodium) - solution - 284mg - inclisiran (inclisiran sodium) 284mg

LEQVIO inclisiran 284 mg /1.5 mL solution for injection in pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

leqvio inclisiran 284 mg /1.5 ml solution for injection in pre-filled syringe

novartis pharmaceuticals australia pty ltd - inclisiran, quantity: 284 mg - injection, solution - excipient ingredients: sodium hydroxide; phosphoric acid; water for injections - leqvio is indicated as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (ldl-c) in adults with heterozygous familial hypercholesterolaemia, atherosclerotic cardiovascular disease, or at high risk of a cardiovascular event:,? in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach ldl-c goals with the maximum tolerated dose of a statin or,,? alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant.

Xeomin New Zealand - English - Medsafe (Medicines Safety Authority)

xeomin

pharmacy retailing (nz) ltd t/a healthcare logistics - botulinum toxin type a 100 units equivalent to incobotulinumtoxina (usan), purified botulinum toxin type a - powder for injection - 100 units - active: botulinum toxin type a 100 units equivalent to incobotulinumtoxina (usan), purified botulinum toxin type a excipient: albumin sucrose - xeomin is indicated in adults for the treatment of: · cervical dystonia · blepharospasm · spasticity of the upper limb · upper facial lines -glabellar frown lines -lateral periorbital lines (crow's feet) - horizontal forehead lines